Letybo

A neurotoxin injection at the forehead. Several small injections are placed across the muscle rather than one large one in the middle.
Both are botulinum toxin type A, and both smooth the frown lines between the brows. The real split is coverage: Xeomin is also approved for the forehead and crow's feet, and Letybo is not. Letybo is newer here and is often offered at a lower price. No trial has ever compared the two.
| The difference | Letybo | Xeomin |
|---|---|---|
| Cost | Often offered at a lower price | Priced per unit, out of pocket |

A neurotoxin injection at the forehead. Several small injections are placed across the muscle rather than one large one in the middle.

A neurotoxin injection at the inner brow. Xeomin carries no accessory proteins around the toxin, which is the one real difference from the others at the point of injection.
Side by side
Letybo
Several small shots, a few minutes
Small injections into the muscle. How many shots you get depends on how many areas are treated, not on the brand.
Xeomin
Several small shots, a few minutes
The same visit and the same needle. Xeomin can be used across the upper face in one session.
Letybo
Softer frown lines
The vertical lines between the brows relax. That is the only approved area.
Xeomin
Softer lines across the upper face
The same effect between the brows. It is also used on the forehead and around the eyes.
Letybo
20 units
Given as five small shots.
Xeomin
20 units
Also five small shots.
Letybo
Often offered at a lower price
You pay for this yourself. Insurance does not cover it.
Xeomin
Priced per unit, out of pocket
A price per unit tells you nothing across brands, because a unit of one is not a unit of the other. Ask for the price of the whole visit.
Letybo
No home version exists
Creams and serums sold as "Botox in a bottle" sit on the surface of the skin. The muscle that makes a frown line is several millimetres down. A cream cannot reach it.
Xeomin
No home version exists
The same answer. Xeomin is placed in the muscle by an injector, and nothing sold over the counter does that.
Letybo
Xeomin
Xeomin
Xeomin is one of only two brands approved for the whole upper third of the face. Botox Cosmetic is the other. Letybo is not, and neither are Dysport, Jeuveau or Daxxify.
Xeomin
Xeomin has no helper proteins around the toxin. Most brands wrap the toxin in extra proteins. Xeomin does not, and that is the basis of the claim: fewer foreign proteins give the immune system less to react to.
Xeomin is not the only bare toxin. Daxxify has no helper proteins either. If the argument holds, it holds for both.
Letybo
Letybo (letibotulinumtoxinA-wlbg) is approved in the US for glabellar frown lines only, at 20 units given as five injections of 4 units. It holds no therapeutic indications in the US. FDA approval came in 2024 and US launch followed in 2025. Approval rested on three placebo-controlled trials in about 1,270 subjects.
Xeomin
Xeomin (incobotulinumtoxinA) is approved for glabellar lines, horizontal forehead lines and lateral canthal lines. The forehead and crow's feet indications were added in July 2024. The forehead indication is 20 units in five injections of 4 units, and applies only when the glabellar lines are treated concurrently. The label caps combined treatment of all three upper-face areas at 64 units per session. Xeomin has been in US use since 2010 and also holds therapeutic indications including cervical dystonia and chronic sialorrhea.
Common questions
Treating the forehead is off-label for nearly every brand. That is normal, legal and very common. It does mean the FDA never reviewed the dose or the safety data for that area.
If you are treating frown lines only, none of this affects you. Both are approved for that area.
Botulinum toxin can cause drooping or weakness. Seek urgent care for trouble swallowing or breathing. Discuss the specific product’s warnings with your injector.